JPWO2023030272A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2023030272A5
JPWO2023030272A5 JP2024513196A JP2024513196A JPWO2023030272A5 JP WO2023030272 A5 JPWO2023030272 A5 JP WO2023030272A5 JP 2024513196 A JP2024513196 A JP 2024513196A JP 2024513196 A JP2024513196 A JP 2024513196A JP WO2023030272 A5 JPWO2023030272 A5 JP WO2023030272A5
Authority
JP
Japan
Prior art keywords
seq
hcdr2
hcdr1
hcdr3
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024513196A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024534847A (ja
JP2024534847A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/115590 external-priority patent/WO2023030272A1/zh
Publication of JP2024534847A publication Critical patent/JP2024534847A/ja
Publication of JP2024534847A5 publication Critical patent/JP2024534847A5/ja
Publication of JPWO2023030272A5 publication Critical patent/JPWO2023030272A5/ja
Pending legal-status Critical Current

Links

JP2024513196A 2021-08-30 2022-08-29 抗gprc5d抗原結合タンパク質とその使用 Pending JP2024534847A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN202111004998.9 2021-08-30
CN202111004998 2021-08-30
PCT/CN2022/115590 WO2023030272A1 (zh) 2021-08-30 2022-08-29 抗gprc5d抗原结合蛋白及其用途

Publications (3)

Publication Number Publication Date
JP2024534847A JP2024534847A (ja) 2024-09-26
JP2024534847A5 JP2024534847A5 (https=) 2025-03-14
JPWO2023030272A5 true JPWO2023030272A5 (https=) 2025-03-14

Family

ID=85410857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024513196A Pending JP2024534847A (ja) 2021-08-30 2022-08-29 抗gprc5d抗原結合タンパク質とその使用

Country Status (5)

Country Link
US (1) US20240384001A1 (https=)
EP (1) EP4397686A4 (https=)
JP (1) JP2024534847A (https=)
CN (1) CN116063500A (https=)
WO (1) WO2023030272A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023134718A1 (zh) * 2022-01-14 2023-07-20 原启生物科技(上海)有限责任公司 靶向gprc5d的嵌合抗原受体及其用途
JP2026511074A (ja) * 2023-03-22 2026-04-10 バイオフロント セラピューティクス (ベイジン) カンパニー リミテッド Gprc5dに結合するナノボディ及びその使用
WO2025011462A1 (en) * 2023-07-07 2025-01-16 Overland Therapeutics (Us) Inc. Single domain antibodies for gprc5d
AR133427A1 (es) 2023-07-31 2025-09-24 Sanofi Sa Anticuerpos anti-gprc5d y composiciones
CN117229407B (zh) * 2023-11-14 2024-02-20 成都优赛诺生物科技有限公司 一种靶向gprc5d的单域抗体、嵌合抗原受体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3227324A4 (en) * 2014-12-05 2018-08-29 Memorial Sloan Kettering Cancer Center Antibodies targeting g-protein coupled receptor and methods of use
SI3227339T1 (sl) 2014-12-05 2022-02-28 Memorial Sloan-Kettering Cancer Center Himerni antigenski receptorji, ki ciljajo na receptor, povezan z G-proteinom, in njihova uporaba
TWI781108B (zh) * 2016-07-20 2022-10-21 比利時商健生藥品公司 抗gprc5d抗體、結合gprc5d與cd3之雙特異性抗原結合分子及其用途
TW201837174A (zh) * 2017-02-07 2018-10-16 日商第一三共股份有限公司 抗gprc5d抗體及包含該抗體之分子
TWI829667B (zh) * 2018-02-09 2024-01-21 瑞士商赫孚孟拉羅股份公司 結合gprc5d之抗體
US12005080B2 (en) * 2018-03-26 2024-06-11 Oricell Therapeutics Co., Ltd. Method for promoting proliferation of immune cells
MA54079A (fr) * 2018-11-01 2021-09-08 Juno Therapeutics Inc Récepteurs antigéniques chimériques spécifiques du gprc5d (élément d du groupe 5 de classe c des récepteurs couplés à la protéine g)
JP2022543551A (ja) * 2019-07-31 2022-10-13 エフ・ホフマン-ラ・ロシュ・アクチェンゲゼルシャフト Gprc5dに結合する抗体
KR20220122656A (ko) * 2019-12-06 2022-09-02 주노 쎄러퓨티크스 인코퍼레이티드 Gprc5d-표적화 결합 도메인에 대한 항-이디오타입 항체 및 관련 조성물 및 방법

Similar Documents

Publication Publication Date Title
Azuma Co-signal molecules in T-cell activation: historical overview and perspective
JP2020533958A5 (https=)
IL317912A (en) A combined chimeric antigen receptor targeting CD19 and CD20 and its applications
JP2017524367A5 (https=)
IL277398B2 (en) Pd-l1 binding affimers, and uses related thereto
JP2021500881A5 (https=)
JP2020511529A5 (https=)
JP2019523301A5 (https=)
JP2018535701A5 (https=)
JP2022501043A5 (https=)
JP2018527014A5 (https=)
RU2017105160A (ru) Лечение рака с помощью химерного антигенного рецептора к cd33
CA3180321A1 (en) Multifunctional molecules that bind to t cell related cancer cells and uses thereof
CN115916833A (zh) 靶向b7h3的抗原结合多肽及其应用
JPWO2020061498A5 (https=)
TW202342550A (zh) 靶向bcma和gprc5d的嵌合抗原受體及其應用
US20240384001A1 (en) Anti-gprc5d antigen binding protein and use thereof
JPWO2020228825A5 (https=)
Sakanishi et al. Anti-tumor effects of depleting and non-depleting anti-CD27 monoclonal antibodies in immune-competent mice
JPWO2020228824A5 (https=)
JPWO2022151851A5 (https=)
JPWO2020102422A5 (https=)
JP2020500903A5 (https=)
JPWO2019245991A5 (https=)
JPWO2023030272A5 (https=)